• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.

作者信息

Ortoleva Jamel P, Cobey Frederick C

机构信息

Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.

Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, MA.

出版信息

J Cardiothorac Vasc Anesth. 2019 May;33(5):1310-1314. doi: 10.1053/j.jvca.2018.11.025. Epub 2018 Nov 24.

DOI:10.1053/j.jvca.2018.11.025
PMID:30598380
Abstract
摘要

相似文献

1
A Systematic Approach to the Treatment of Vasoplegia Based on Recent Advances in Pharmacotherapy.基于药物治疗最新进展的血管麻痹治疗系统方法。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1310-1314. doi: 10.1053/j.jvca.2018.11.025. Epub 2018 Nov 24.
2
Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.亚甲蓝单药治疗与羟钴胺联合治疗难治性血管扩张性休克的疗效比较：一项回顾性队列研究。
J Cardiothorac Vasc Anesth. 2019 May;33(5):1301-1307. doi: 10.1053/j.jvca.2018.11.020. Epub 2018 Nov 16.
3
Hydroxocobalamin for Vasoplegic Syndrome in Liver Transplantation: Restoration of Blood Pressure Without Vasospasm.用于肝移植中血管麻痹综合征的羟钴胺：恢复血压且无血管痉挛
A A Case Rep. 2016 Dec 15;7(12):247-250. doi: 10.1213/XAA.0000000000000398.
4
The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.静脉注射羟钴胺素在心脏手术中对亚甲蓝抵抗性血管麻痹综合征的抢救应用。
Ann Card Anaesth. 2017 Oct-Dec;20(4):462-464. doi: 10.4103/aca.ACA_88_17.
5
Methylene blue is not a pure vasoconstrictor drug.亚甲蓝不是一种单纯的血管收缩剂药物。
Ann Card Anaesth. 2016 Apr-Jun;19(2):340-1. doi: 10.4103/0971-9784.179593.
6
Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.羟钴胺素治疗血管麻痹：当前文献综述及使用考量
J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.
7
Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.体外循环期间的血管麻痹：当前文献和抢救治疗选择。
J Cardiothorac Vasc Anesth. 2020 Oct;34(10):2766-2775. doi: 10.1053/j.jvca.2019.12.013. Epub 2019 Dec 14.
8
Adjuvant therapy with methylene blue in the treatment of postoperative vasoplegic syndrome caused by carcinoid crisis after tricuspid valve replacement.亚甲蓝辅助治疗三尖瓣置换术后类癌危象所致术后血管麻痹综合征。
J Cardiothorac Vasc Anesth. 2012 Oct;26(5):878-9. doi: 10.1053/j.jvca.2011.03.180. Epub 2011 Jun 8.
9
Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.羟钴胺素（维生素 B12a）在体外循环后血管加压药抵抗性低血压患者中的应用：病例系列。
Anesth Analg. 2019 Jul;129(1):e1-e4. doi: 10.1213/ANE.0000000000003648.
10
Use of Intravenous Hydroxocobalamin for Vasoplegic Syndrome in Simultaneous Liver-Kidney Transplant: A Case Report.静脉注射羟钴胺素治疗肝肾联合移植中血管扩张性综合征：一例报告。
Transplant Proc. 2021 May;53(4):1300-1302. doi: 10.1016/j.transproceed.2020.09.019. Epub 2020 Nov 24.

引用本文的文献

1
Methylene blue in the critical care setting.重症监护环境中的亚甲蓝。
World J Crit Care Med. 2025 Sep 9;14(3):105350. doi: 10.5492/wjccm.v14.i3.105350.
2
Refractory Vasoplegia in a Patient with Acute Aneurysmal Subarachnoid Hemorrhage.急性动脉瘤性蛛网膜下腔出血患者的难治性血管麻痹
Neurocrit Care. 2025 May 29. doi: 10.1007/s12028-025-02290-5.
3
Severe Refractory Vasoplegic Shock Syndrome after OPCABG Successfully Treated with Hydroxycobalamin: A Case Report and Review of the Literature.羟钴胺成功治疗非体外循环冠状动脉搭桥术后严重难治性血管麻痹性休克综合征：一例报告并文献复习
J Clin Med. 2023 Dec 28;13(1):169. doi: 10.3390/jcm13010169.
4
Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study.静脉注射亚甲蓝能否改善难治性感染性休克患者的血流动力学及预后？一项观察性研究。
Indian J Crit Care Med. 2023 Sep;27(9):669-674. doi: 10.5005/jp-journals-10071-24535.
5
Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia.羟钴胺作为难治性氨氯地平诱导的血管麻痹患者的抢救治疗药物
Cureus. 2023 May 1;15(5):e38400. doi: 10.7759/cureus.38400. eCollection 2023 May.
6
Ketamine, interleukin-6, and vasoplegia: Is prevention the best medicine?氯胺酮、白细胞介素-6与血管麻痹：预防是最佳疗法吗？
Ann Card Anaesth. 2023 Jan-Mar;26(1):114-116. doi: 10.4103/aca.aca_31_21.
7
How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review.血管紧张素II在降低血管舒张性休克死亡率方面的效果如何？一项系统评价。
Open Access Emerg Med. 2023 Jan 5;15:1-11. doi: 10.2147/OAEM.S391167. eCollection 2023.
8
Protocol Compliance Guiding Angiotensin II Use in Post Cardiovascular Surgery Vasoplegia.心血管手术后血管麻痹中血管紧张素II使用的方案依从性指导
Crit Care Explor. 2022 May 13;4(5):e0687. doi: 10.1097/CCE.0000000000000687. eCollection 2022 May.
9
Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study.甲烯蓝在重症监护病房血管扩张性休克中的应用：回顾性观察研究。
BMC Anesthesiol. 2022 Jun 27;22(1):199. doi: 10.1186/s12871-022-01739-w.
10
Vasoplegia Following Complex Spine Surgery: Incidence and Risk.复杂脊柱手术后的血管麻痹：发生率与风险
Global Spine J. 2024 Mar;14(2):400-406. doi: 10.1177/21925682221105823. Epub 2022 May 29.